OSR Health, Inc.

As of June 30, 2026, OSR Health, Inc. carries a market capitalization of 11.11M, placing it among publicly traded companies globally. Its enterprise value stands at 35.71M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

OSR Health, Inc.'s next confirmed earnings release is scheduled for December 2, 2026.

As of June 30, 2026, OSR Health, Inc. has 35.12M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 5.31, and the price-to-book ratio stands at 0.11.

These figures are as of June 30, 2026. The EV/Sales ratio of 19.74 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 35.71M versus a market cap of 11.11M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, OSR Health, Inc. maintains a current ratio of 0.18, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.37, indicating elevated leverage, while an interest coverage ratio of -14.93 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, OSR Health, Inc. posted a negative return on equity (ROE) of -11.42, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -6.10, reflecting losses generated across the asset base. The company generates approximately 85,117.29 in revenue per employee across its workforce of 21.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.95 indicates how many times OSR Health, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, OSR Health, Inc. recorded an income tax benefit of -2.72M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -17.63M and -10.73M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on August 25, 2026, OSR Health, Inc.'s stock has declined approximately 88.47% over the past 52 weeks. The 50-day moving average sits at 0.38, while the 200-day moving average is 0.51.

Over the twelve months ended June 30, 2026, OSR Health, Inc. generated 1.81M in revenue and converted that into -10.73M in net income, yielding earnings per share of -0.48. EBITDA reached -7.42M, while operating income came in at -16.89M.

As of June 30, 2026, OSR Health, Inc. holds 1.50M in cash and equivalents against 5.46M in total debt, resulting in a net debt position of 3.93M. Total book value stands at 104.27M, with working capital of -12.87M providing operational flexibility.

OSR Health, Inc. produced -7.20M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -79,514.00 in capital expenditures, free cash flow totaled -7.28M - equivalent to -0.24 per share.

Over the twelve months ended June 30, 2026, OSR Health, Inc. posted a gross margin of 35.29, reflecting its pricing power and cost economics. The operating margin of -933.75 and net profit margin of -593.22 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -73.94: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -96.71, meaning OSR Health, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, OSR Health, Inc. has an Altman Z-Score of -38.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.